<DOC>
	<DOCNO>NCT00460369</DOCNO>
	<brief_summary>Malaria life-threatening disease especially small child . A high degree Plasmodium falciparum resistance chloroquine already spread South-Benin study take place . In past year , recommendation first-line treatment area move chloroquine sulfadoxine-pyrimethamine ( SP ) . There grow evidence Plasmodium falciparum resistance SP come South-Benin . The aim study compare efficacy SP two compact artemisinin-based therapy ( ACT ) : artemether-lumefantrine amodiaquine-artesunate coformulation . ACT unsupervised . The primary endpoint effectiveness comparison ( PCR correct ) day 28 . Secondary outcome effectiveness comparison ( PCR correct ) day 14 42 study relationship ACT PK data ( day 3 ) outcome . Expected total enrollment : 225 patient Study start : April 2007 ; expect completion : December 2007</brief_summary>
	<brief_title>Treatment Uncomplicated Malaria Benin</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<criteria>6119 month old fever history fever less 24 hour p falciparum parasitemia &gt; 1000 trophozoïtes/µL inform consent sign &lt; 5 kg danger severity sign malaria know underlie chronic disease Hb &lt; 5g/dL adequate malaria treatment take within 3 day visit</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>119 Months</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>uncomplicated malaria</keyword>
	<keyword>child</keyword>
	<keyword>treatment</keyword>
	<keyword>effectiveness</keyword>
</DOC>